Maximus (FRA:MMY) ROCE %: 16.72% (As of Mar. 2026)

What is Maximus ROCE %?

Maximus FRA:MMY -3.32% 75 ROCE % is 16.72% as of Mar. 2026. GuruFocus rates FRA:MMY with a GF Score™ of 75/100 and a GF Value™ of €77.66 (Significantly Undervalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Maximus's annualized ROCE % for the quarter that ended in Mar. 2026 was 16.72%.

Maximus (FRA:MMY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Maximus ROCE % Related Terms

Maximus ROCE % Historical Data

* Premium members only.

The historical data trend for Maximus's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maximus ROCE % Chart

Maximus Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Sep25

ROCE %

Get a 7-Day Free Trial

16.63

10.73

8.75

14.56

15.51

Maximus Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															17.67	17.74	13.80	17.06	16.72

75GF Score

Maximus Inc FRA:MMY

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Maximus ROCE % Calculation

Maximus's annualized ROCE % for the fiscal year that ended in Sep. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Sep. 2025 )		(A: Sep. 2024 )		(A: Sep. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Sep. 2025 )		(A: Sep. 2024 )		(A: Sep. 2025 )
	=	450.648	/	( ( (3722.489 - 727.584)	+	(3467.332 - 651.919) )	/ 2 )
	=	450.648	/	( (2994.905	+	2815.413)	/ 2 )
	=	450.648	/	2905.159
	=	15.51 %

Maximus's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	514.312	/	( ( (3593.888 - 519.271)	+	(3666.886 - 589.659) )	/ 2 )
	=	514.312	/	( ( 3074.617	+	3077.227 )	/ 2 )
	=	514.312	/	3075.922
	=	16.72 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 16.72% mean?

Maximus (FRA:MMY) has a ROCE % of 16.72% as of Mar. 2026.

Is Maximus' ROCE % too high?

Maximus' current ROCE % is 16.72%. The Business Services industry median ROCE % is 8.82. Maximus' value of 16.72% is 89.6% above this industry median. Overall, Maximus has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Maximus' ROCE % compare to FA and AZZ?

Maximus' ROCE % of 16.72% can be compared against companies in the Business Services industry. The industry median ROCE % is 8.82. Maximus' value of 16.72% is 89.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Business Services company?

The median ROCE % among Business Services companies is 8.82, based on 1,070 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maximus's current ROCE % of 16.72% is 89.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Business Services industry, the median ROCE % is 8.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maximus's current ROCE % is 16.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Maximus stock overvalued right now?

Based on GuruFocus' analysis, Maximus (FRA:MMY) is currently considered Significantly Undervalued. The stock's GF Value™ is €77.66, compared to a current price of €46.60 — trading 40% below its estimated fair value. The current ROCE % is 16.72% and 89.6% above the Business Services industry median of 8.82. Maximus' overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Maximus (FRA:MMY), the current ROCE % is 16.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Maximus (FRA:MMY) Overvalued in 2026?

Based on GuruFocus' analysis, Maximus stock appears to be undervalued. The current stock price of €46.60 is trading 40% below its estimated GF Value™ of €77.66. GuruFocus considers Maximus to be Significantly Undervalued.

Key valuation signals for FRA:MMY:

ROCE %: 16.72%
GF Value™: €77.66 vs. price of €46.60 (40% below fair value)
GF Score™: 75/100 with 2 warning signs
Industry Position: 89.6% above the Business Services median

No single metric tells the full story. See the FRA:MMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Maximus Business Description

Industry Industrials Business Services

Comparable Companies FA AZZ CMPR ABM TIC BKSY CBZ TH UNF DLB CTAS LSE:REL TSX:TRI CPRT GPN ULS TSX:RBA ASX:BXB XAMS:WKL LSE:RTO

Other Exchanges MMS:USA

Address 1600 Tysons Boulevard, McLean, VA, USA, 22102

Website https://www.maximus.com

Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

75GF Score

Get the complete analysis for FRA:MMY

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€46.60

Price

€77.66

GF Value

View FRA:MMY Analysis

See ROCE % data for all stocks →